MONTREUX EQUITY PARTNERS II SBIC LP's Net Worth
$8.68 Million
Who is MONTREUX EQUITY PARTNERS II SBIC LP?
MONTREUX EQUITY PARTNERS II SBIC LP has an estimated net worth of $8.68 Million. This is based on reported shares across multiple companies, which include NeurogesX Inc, QUESTCOR PHARMACEUTICALS INC, and Somaxon Pharmaceuticals, Inc..
SEC CIK
MONTREUX EQUITY PARTNERS II SBIC LP's CIK is 0001277894
Past Insider Trading and Trends
2004 was MONTREUX EQUITY PARTNERS II SBIC LP's most active year for acquiring shares with 2 total transactions. MONTREUX EQUITY PARTNERS II SBIC LP's most active month to acquire stocks was the month of April. 2010 was MONTREUX EQUITY PARTNERS II SBIC LP's most active year for disposing of shares, totalling 1 transactions. MONTREUX EQUITY PARTNERS II SBIC LP's most active month to dispose stocks was the month of February. 2009 saw MONTREUX EQUITY PARTNERS II SBIC LP paying a total of $999,997.85 for 1,702,124 shares, this is the most they've acquired in one year. In 2010 MONTREUX EQUITY PARTNERS II SBIC LP cashed out on 1,500,000 shares for a total of $9,573,600.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
NeurogesX Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
QUESTCOR PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Somaxon Pharmaceuticals, Inc. No price found
InvestorMONTREUX EQUITY PARTNERS II SBIC LP owns 695,505 units of Common Stock. In the year 2009 MONTREUX EQUITY PARTNERS II SBIC LP acquired a total of 851,062 shares in Somaxon Pharmaceuticals, Inc. at a cost of $893,615.10, MONTREUX also disposed a total of 1,500,000 shares of Somaxon Pharmaceuticals, Inc. equalling to $9,573,600.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -68.32% | -1.50M |
$6.38 | -$9,573,600.00 | 695.5K |
Mar 18
| |||
Form 4
| +63.30% | 851.06K |
$1.05 | $893,615.10 | 2.2M |
Jul 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||